Angel Insights | Your guide to angel investing
What Is A Reasonable IRR For Angel Investors with Tim Mills @ British Business Bank
22 Jun 2016
Tim Mills is an Investment Director at the newly formed British Business Bank and also leads the investment activity and operations of the Angel CoFund. Tim started his career with Merrill Lynch where he became an Associate Vice President in the technology group at Merrill before moving to Barclays Capital to work on the integration of the firm's expanding global operations. In the past Tim has worked with a leading credit analytics consultancy and one of the UKs largest hedge funds.Prior to the creation of the British Business Bank, Tim spent 5 years with Capital for Enterprise, leading investments into venture capital funds as well as launching various funds, including the Angel CoFund. In Today's Episode You Will Learn: 1.) How Tim made his way into he world of tech and investing? 2.) How Tim has applied his learnings from investing in funds to investing in startups? 3.) What does Tim look for in co-investors? What are the optimal traits that Tim assesses? 4.) How has Tim seen the early stage investing ecosystem evolve and develop over the last 10 years? 5.) What is the English tech environment doing well at and what does it need to improve on? As always, you can learn more about SyndicateRoom here: www.syndicateroom.com
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2426 - Cameron Hanes & Adam Greentree
16 Dec 2025
The Joe Rogan Experience
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Donβt Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare